Literature DB >> 26018851

Neuroleptic malignant syndrome and delirious mania as malignant catatonia in autism: prompt relief with electroconvulsive therapy.

L Wachtel1, E Commins2, M Park2, N Rolider2, R Stephens3, I Reti4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26018851     DOI： 10.1111/acps.12441

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN： 0001-690X            Impact factor:   6.392


× No keyword cloud information.
  4 in total

1.  High-Frequency Stimulation at the Subthalamic Nucleus Suppresses Excessive Self-Grooming in Autism-Like Mouse Models.

Authors:  Andrew D Chang; Victoria A Berges; Sunho J Chung; Gene Y Fridman; Jay M Baraban; Irving M Reti
Journal:  Neuropsychopharmacology       Date:  2015-11-26       Impact factor: 7.853

2.  Clinical response of clozapine as a treatment for delirious mania.

Authors:  Nabeel Wahid; Garwin Chin; Andia H Turner; Alexis Seegan
Journal:  Ment Illn       Date:  2017-10-23

3.  Far From an Elective Procedure: Electroconvulsive Therapy and Autism in the Era of COVID-19.

Authors:  Lee Elizabeth Wachtel
Journal:  J ECT       Date:  2021-03-01       Impact factor: 3.692

4.  Neuroleptic Malignant Syndrome in Children with Autism Spectrum Disorder (ASD): A Case Report and Brief Review of Recent Literature.

Authors:  Stefano Berloffa; Claudia Dosi; Benedetta Tascini; Beatrice Fossati; Ilaria Lupetti; Gabriele Masi
Journal:  Children (Basel)       Date:  2021-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.